Compound information
- Natural Products
- ZC1850298
- Molecular Formula
- C19H20N6OS
- Molecular Weight
- 380.14193026 g/mol
- Structure
-
- IUPAC Name
- 4-(2-methyl-4-pyridyl)-N-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
- InChI
- InChI=1S/C19H20N6OS/c1-14-13-16(7-8-20-14)24-9-11-25(12-10-24)19(26)22-18-21-17(23-27-18)15-5-3-2-4-6-15/h2-8,13H,9-12H2,1H3,(H,21,22,23,26)
- InChI Key
- NLVKIKPXHCWACV-UHFFFAOYSA-N
- SMILES
- Cc1cc(N2CCN(C(=O)Nc3nc(-c4ccccc4)ns3)CC2)ccn1
- Source
- ZINC000055326825
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 74.25 Å2 | LogP | 3.402 |
LogS | -4.554 | LogD | 3.979 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.538 | Pgp substrate | 0.985 |
HIA | 0.968 | F20 % | 0.992 |
F30 % | 0.977 | Caco-2 | -4.548 |
MDCK | -5.218 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.254 | PPB | 97.223 |
VD | 0.989 | Fu | 1.573 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.978 | CYP1A2 substrate | 0.805 |
CYP2A6 substrate | 0.274 | CYP2B6 substrate | 0.737 |
CYP2C19 inhibitor | 0.921 | CYP2C19 substrate | 0.78 |
CYP2C8 substrate | 0.701 | CYP2C9 inhibitor | 0.975 |
CYP2C9 substrate | 0.465 | CYP2D6 inhibitor | 0.047 |
CYP2D6 substrate | 0.929 | CYP2E1 substrate | 0.41 |
CYP3A4 inhibitor | 0.555 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.594 | CL | 4.129 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.33 | Hepatotoxicity | 0.695 |
Mutagenicity | 0.026 | Rat Oral Acute Toxicity | 0.228 |
FDAMDD | 0.365 | Skin Sensitization | 0.728 |
Carcinogenicity | 0.774 | Eye Corrosion | 0.003 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.992 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.447 | IGC50 | 3.006 |
LC50FM | -2.885 | LC50DM | -6.548 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.712 | NR-AR-LBD | 0.316 |
NR-AhR | 0.961 | NR-Aromatase | 0.028 |
NR-ER | 0.744 | NR-ER-LBD | 0.341 |
NR-PPAR-gamma | 0.682 | SR-ARE | 0.892 |
SR-ATAD5 | 0.875 | SR-HSE | 0.137 |
SR-MMP | 0.518 | SR-p53 | 0.447 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.